LS CancerDiag at the Startup Health Festival

LS CancerDiag at the Startup Health Festival

Back in January, our CBO Philippe Arnez spent two days at the Startup Health Festival in San Francisco.

LS CancerDiag is proud to be part of this dynamic and inspiring community. We are glad to have had a delegate representing the company and sharing our mission and vision. It was also a good opportunity to reconnect with fellow health transformers and industry leaders in health care.

Like LS CancerDiag, these enterpreneurs, corporations and organizations are committed to transform health care in radical ways to achieve their health moonshot. In the case of LS CancerDiag it is to end cancer through prevention. By improving the detection of Lynch syndrome, which is the most common hereditary cancer predisposition. The company joined this ‘global army of health transformers’ in 2016 and was one of the first Finnish companies to be accepted into this illustrious circle. StartUp Health provides valuable support, in particular in view of a future market entry to the US. They have a extensive network and are an influential platform to help building our DiagMMR® brand.

Philippe was also interviewed by Logan Plaster at StartUp Health TV  during the event, sharing what LS CancerDiag is all about, the latest developments and achievements. But most importantly, what 2020 will bring, have a look!

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.